A Comparison of the Prevalence of Metabolic Syndrome According to Different Definitions in Climacteric Women

Reis, Vivianne Margareth Chaves Pereira; Rocha, Josiane Santos Brant; Fonseca, Alenice Aliane; Freitas, Ronilson Ferreira; Passos, Betânia Maria Araújo; Baldo, Marcelo Perim; Freire, Rafael Silveira; Reis, Gabriel Chaves Veloso; Oliveira, Fernanda Piana Santos Lima de; Magalhães, Tatiana Almeida de; Silveira, Marise Fagundes

doi:10.1089/met.2020.0143

Cited by 3 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…De igual forma, en otras poblaciones de Latinoamérica se evidencia porcentajes semejantes como un estudio realizado en Venezuela, expresando un mayor valor dentro de las definiciones ALAD y NCEP/ATP III con el 39,1% y 38,3% respectivamente 27 . En Perú se identificó prevalencia del síndrome en una población de 260 individuos con el 46,2% bajo los criterios ALAD y del 48,1% IDF/NHLBI/AHA 28 , finalmente, agregando a lo anterior, Brasil demuestra prevalencias similares al estudio bajo los criterios IDF/NHLBI/AHA con el 56,9% 29 .…”

Section: Discussionunclassified

Comparación de criterios diagnósticos del síndrome metabólico en un Centro de Atención Primario Rural

2022

View full text Add to dashboard Cite

Objetivo: Comparar los criterios de diagnóstico del síndrome metabólico en base a las definiciones NCEP/ATP-III, ALAD y IDF/NHLBI/AHA a partir de su prevalencia en una población de 18-65 años de un centro de atención primario rural durante el periodo 2021. Método: Observacional descriptivo, no experimental, cuya muestra estuvo constituida por 267 individuos. Resultados: Detallando que se evidenció un predominio del sexo masculino, el cual oscilaba entre los 27-69 años; además que el 89,8% presentaba un IMC normal. La prevalencia fue del 59,2% bajo IDF /NHLBI/AHA, seguido de ALAD con 41,9% y 33,7% NCEP/ATP-III. Así mismo, se observó una concordancia moderada entre NCEP/ATP-III y IDF /NHLBI/AHA y escasa entre NCEP/ATP-III y ALAD; ALAD y IDF /NHLBI/AHA. Conclusión: El síndrome metabólico debe ser valorado bajo criterios más específicos y adaptativos para la población a nivel regional, con el fin de proporcionar datos pertinentes para futuros estudios.

show abstract

Section: Discussionunclassified

Comparación de criterios diagnósticos del síndrome metabólico en un Centro de Atención Primario Rural

2022

View full text Add to dashboard Cite

show abstract

“…MetS is spread widely throughout the population and its prevalence is continually rising, causing serious health problems. According to a cross-sectional population study in Brazil, the prevalence of MetS in menopausal women was 56.9% [ 31 ]. In a study on postmenopausal women in Poland, the prevalences of MetS were 70% and 22% in rural and urban areas, respectively [ 32 ].…”

Section: Introductionmentioning

confidence: 99%

Metabolic Syndrome, BMI, and Polymorphism of Estrogen Receptor-α in Peri- and Post-Menopausal Polish Women

et al. 2022

View full text Add to dashboard Cite

The study aimed to investigate the association between the estrogen receptor alpha (ERα) polymorphism and the prevalence of metabolic syndrome (MetS) and obesity, as well as the coexistence of MetS and obesity, in peri- and post-menopausal Polish women. The study group consisted of 202 peri-menopausal and 202 post-menopausal women. ERα polymorphism: Xba I and Pvu II, MetS, BMI, and serum estrogen concentration were analyzed. MetS was found in 29% of the peri-menopausal women and in 21% of the post-menopausal women. BMI did not significantly differ between the peri- and post-menopausal women (≈42% were normal weight, ≈40% were overweight, and ≈18% were obese), (p = 0.82). Serum estrogen concentration in the peri-menopausal women was 91 ± 75 pg/mL, while that in the post-menopausal women was 17 ± 9. pg/mL, on average. Peri-menopausal women with AA and TT genotypes of the ERα polymorphism have a lower risk of obesity and MetS and the co-existence of obesity and MetS, whereas those women with the G or C allele have a higher risk of those health problems.

show abstract

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers

Lonardo

2023

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

A Comparison of the Prevalence of Metabolic Syndrome According to Different Definitions in Climacteric Women

Cited by 3 publications

References 19 publications

Comparación de criterios diagnósticos del síndrome metabólico en un Centro de Atención Primario Rural

Comparación de criterios diagnósticos del síndrome metabólico en un Centro de Atención Primario Rural

Metabolic Syndrome, BMI, and Polymorphism of Estrogen Receptor-α in Peri- and Post-Menopausal Polish Women

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers

Contact Info

Product

Resources

About